Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
9,736,498
-
Total 13F shares
-
5,217,399
-
Share change
-
+319,267
-
Total reported value
-
$188,361,504
-
Price per share
-
$36.07
-
Number of holders
-
34
-
Value change
-
+$11,625,261
-
Number of buys
-
19
-
Number of sells
-
15
Institutional Holders of Bright Minds Biosciences Inc. - Common Shares (DRUG) as of Q1 2025
As of 31 Mar 2025,
Bright Minds Biosciences Inc. - Common Shares (DRUG) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,217,399 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, Sio Capital Management, LLC, COMMODORE CAPITAL LP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.